REPL
#2280
Replimune Group, Inc. - Common Stock
12.5 0 USD
-0.04%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-4.36%
Variación mensual
-3.62%
Variación en los últimos 6 meses
+622.54%
Cambio anual
+178.40%
Cierres anteriores
13.0 7
Open
12.9 1
Mínimo
12.3 0
Máximo
12.9 3
Financials
- Market Capitalization 1.18 B
- Employee 465
- Founded 2015
- CEO N/A
- Website www.replimune.com
- Headquarter Delaware, United States
- FIGI BBG00L8Z22R1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-2.26
Relación precio/flujo de caja
753.66
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2273 |  GHRS GH Research PLC - Ordinary Shares | 19.05 USD | -4.85% | -12.41% | -29.96% | +34.53% | 1.18 B USD | ||
| 2274 |  ORIC Oric Pharmaceuticals, Inc. - Common Stock | 11.58 USD | -1.95% | -3.18% | -4.14% | -14.29% | 1.20 B USD | ||
| 2295 |  VOR Vor Biopharma Inc. - Common Stock | 19.78 USD | -0.10% | +6.75% | -11.66% | +50.99% | 1.17 B USD | ||
| 2304 |  LBRX LB Pharmaceuticals Inc - Common Stock | 35.34 USD | -1.64% | +1.55% | -21.38% | +121.43% | 1.14 B USD |